Please login to the form below

Not currently logged in
Email:
Password:

NHS 'not driving' health innovation

Minister for Life Sciences acknowledges UK has more to do

edit-george-freeman

Minister for Life Sciences George Freeman admitted that more must to be done to improve the uptake of innovation in the NHS.

He joined pharma leaders on a panel last week discussing how regional initiatives can forge new R&D investment, collaboration and innovation in life sciences.

Freeman said, “I don't think anyone would say the NHS is a catalyst for health innovation. We are still not good enough at adopting innovation into industry, especially within the NHS.”

The comments come just weeks after a Cancer Research UK report warned NHS cancer services in England are at a “tipping point” after efficiency savings and recent NHS reforms.

Also speaking at the London event, which was organised by comms agency Hanover, was ABPI president and Pfizer UK's managing director Jonathan Emms.

He noted that more work is needed to utilise all medication created in the UK, as many go through the expensive clinical process but remain unused.

Emms also called for the government's science budget to be “sustained and ring fenced” after David Cameron reportedly referred to the life sciences sector as “a jewel in the crown”.

The discussion at the event, whose speakers also included MedCity's Eliot Forster and the Northern Health Science Alliance's Ian Greer, repeatedly returned to the impending Scottish referendum vote and the impact independence could have on the pharma and biopharma industry.

Article by
Kirstie Pickering

16th September 2014

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics